Search by Drug Name or NDC

    NDC 41163-0883-30 Senna S 50; 8.6 mg/1; mg/1 Details

    Senna S 50; 8.6 mg/1; mg/1

    Senna S is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by EQUALINE (SuperValu). The primary component is DOCUSATE SODIUM; SENNOSIDES.

    Product Information

    NDC 41163-0883
    Product ID 41163-883_59e588de-9aa6-4f6a-8e77-0bd759c25bed
    Associated GPIs
    GCN Sequence Number 048044
    GCN Sequence Number Description sennosides/docusate sodium TABLET 8.6MG-50MG ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 13483
    HICL Sequence Number 021772
    HICL Sequence Number Description SENNOSIDES/DOCUSATE SODIUM
    Brand/Generic Generic
    Proprietary Name Senna S
    Proprietary Name Suffix n/a
    Non-Proprietary Name DOCUSATE SODIUM, SENNOSIDES
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 50; 8.6
    Active Ingredient Units mg/1; mg/1
    Substance Name DOCUSATE SODIUM; SENNOSIDES
    Labeler Name EQUALINE (SuperValu)
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part334
    Listing Certified Through 2024-12-31

    Package

    NDC 41163-0883-30 (41163088330)

    NDC Package Code 41163-883-30
    Billing NDC 41163088330
    Package 1 BOTTLE, PLASTIC in 1 BOX (41163-883-30) / 30 TABLET in 1 BOTTLE, PLASTIC
    Marketing Start Date 2021-03-26
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 3f519d42-72bc-4cc3-a43f-14b94a10eb9a Details

    Revised: 11/2022